Articles tagged with Eye Diseases
Scientists at NTU Singapore have developed a flexible, human cornea-thin battery that can store electricity from saline solution. The battery could power smart contact lenses with displays and augmented reality capabilities.
A study at the University of Gothenburg found that preterm babies given a supplement with omega-3 and omega-6 fatty acids had improved visual function by age 2.5. The supplement also seemed to improve the brain's ability to interpret visual impressions.
Researchers have successfully transplanted human microglia cells into mouse retina, creating a model for studying treatments for diabetic retinopathy, glaucoma, and age-related macular degeneration. The study demonstrates the potential of microglial replacement therapy to treat retinal and central nervous system diseases.
A new study published in BMJ Oncology has found that relatively short-term use of immunosuppressant medications to control inflammatory diseases is not associated with an increased risk of developing cancer. The research included over 10,000 participants and tracked their cancer incidence for an average of 10 years.
A study published in Neurology has identified markers of Parkinson's disease in eye scans, detecting the condition up to seven years before clinical presentation. Researchers used AI-powered analysis of retinal images from two large datasets to uncover subtle changes associated with Parkinson's.
Researchers found that rodents exposed to light for the first time in adulthood showed significant plasticity in their brains, challenging previous beliefs about adult brain rigidity. After a month, their brains looked similar to those of healthy controls, with organized visual responses and smaller receptive fields.
A new study found consistent increases in premature cardiovascular disease (CVD) death and disability due to particulate matter air pollution globally. The analysis, published in the Journal of the American Heart Association, revealed a 8.1% rise in age-standardized CVD deaths attributed to outdoor PM pollution between 1990 and 2019.
Researchers demonstrate the potential of optical imaging for safely measuring vocal fold elasticity and pliability. The study found good agreement between Brillouin microspectroscopy results and conventional elasticity measurements.
Researchers developed an innovative optical tool, the Schistoscope, to capture microscopy images of urine samples for efficient detection of Schistosoma haematobium eggs. A two-stage diagnostic framework using deep learning accurately identified and counted eggs in field settings with high sensitivity, specificity, and precision.
A new study published in JAMA Ophthalmology found that vision problems are more common in older adults with dementia. The study of nearly 3,000 older adults showed that even mild vision issues were associated with a higher risk of dementia.
Researchers from Anglia Ruskin University have successfully grown retinal pigment epithelial cells on a nanofibre scaffold treated with fluocinolone acetonide, showing increased resilience and growth. This breakthrough technology has great potential for developing ocular tissue transplantation to treat age-related macular degeneration.
The American Heart Association has funded seven new scientific research projects to explore the connection between migraines, strokes, and cardiovascular disease. The studies will analyze existing datasets using machine learning and aim to create a collaborative group of experts to uncover the causes of increased risk.
The study, published in Advanced Functional Materials, reveals a novel light-activated material that can be used to effectively reshape and thicken damaged corneal tissue, promoting healing and recovery for patients with keratoconus. The technology has tremendous potential to impact millions of people suffering from corneal diseases.
Researchers at WVU have developed a way to view synthetic DNA at the atomic level, enabling them to understand how to change its structure for enhanced scissor-like function. This breakthrough could lead to new technology for medical diagnoses and treatments, including potential therapies for diseases like retinal degeneration and cancer.
University of Melbourne researchers have discovered that T cells patrol the human eye, protecting it from pathogens and inflammation. The study uses a new imaging technique to capture dynamic behavior of these cells in response to different stimuli.
Researchers at Cedars-Sinai have identified two disease-associated changes to the cornea in diabetes patients that delay wound healing. The study proposes three therapeutic pathways that reversed these changes and partially restored wound-healing function, offering new potential treatments for diabetes.
Researchers will explore characteristics of misplaced calcifications in eyes and brains, and their roles in AMD and AD. The team aims to examine calcifications at multiple levels, from atomic structures to aggregated morphologies, and their accumulation in cells and animals.
A national estimate suggests that 795,000 Americans die or are permanently disabled by diagnostic error each year. The top causes of serious harm include stroke, sepsis, and pneumonia.
A randomized controlled trial funded by NIH found low-dose atropine eyedrops to be no better than placebo in slowing myopia progression among US children. The study contradicts previous East Asian trials that showed a benefit from 0.01% atropine. Further research is needed to identify an optimal approach for preventing high myopia.
A team of scientists at Harvard Medical School has identified six chemical cocktails that can restore cellular aging and rejuvenate human cells. The study builds upon the discovery of Yamanaka factors, which can convert adult cells into induced pluripotent stem cells, raising hopes for treating age-related diseases and injuries. The im...
Researchers at Columbia University Irving Medical Center have discovered that an experimental eye drop treatment can reduce swelling and improve blood flow in the retina of mice with retinal vein occlusion, a common eye disease affecting up to 2% of people over age 40. The study found that the eye drops prevented neurons from deteriora...
A new method reveals intricate behaviors of micron-sized particles in real, artificial tears, allowing for customization of eye drops. The study aims to alleviate dry eye syndrome by providing personalized solutions with tailored formulations and characteristics.
A new database linking RNA editing to blood cell differentiation has been established, providing a platform to accelerate research on leukemia and other pathologies. The REDH database includes detailed information on RNA editing sites in healthy and malignant hematopoietic cells.
A new study by researchers at Baylor College of Medicine found that an orally administered probiotic bacterial strain improved dry eye disease in an animal model. The probiotic, Limosilactobacillus reuteri DSM17938, enhanced corneal health and increased goblet cell production in the eyes, suggesting potential treatment benefits.
Researchers found a significant correlation between vitreous humor biomarkers and pathologically confirmed cases of Alzheimer's disease and Chronic Traumatic Encephalopathy. Biomarkers in the vitreous humor may serve as a proxy for neuropathological disease, offering potential early diagnosis and prognostication.
In 2021, 9.6 million Americans had diabetic retinopathy and 1.84 million had vision-threatening forms. The number of people living with diabetes-related eye disease has grown since the last prevalence estimate in 2004.
Researchers developed an innovative imaging approach using two-photon microscopy to analyze retinal microcirculation, revealing significant changes in blood flow that may indicate brain diseases. The study suggests that microcirculation in the retina could serve as a promising predictor of cerebrovascular diseases.
A retrospective analysis of national data found that over 20 million Americans experienced loss of smell or taste after COVID infection, with a large portion never fully recovering these senses. The study estimated that almost 28 million Americans may be left with decreased sense of smell after COVID infection.
Researchers developed Eye2Gene, an AI system that accurately identifies genetic causes of inherited retinal diseases from retinal scans. The system achieved higher accuracy than human experts in identifying causative genes, with a ranking score above 70% in over 70% of cases.
Researchers achieve 3D printing within mini-organs growing in hydrogels, allowing for precise control over shape, activity, and tissue growth. This breakthrough enables the creation of realistic models of organs and disease, with potential applications in cancer research and treatment.
A new study by Flinders University research team led by Professor Justine Smith has found that women are more likely to experience recurrent cases of toxoplasmosis eye disease. The study also revealed significant differences in the type and characteristics of the disease between men and women.
A new study by Anglia Ruskin University found that people with sight loss in the UK are confused by a 'disjointed' certification system, creating barriers to accessing support and benefits. The research highlights inconsistencies in the process, long waiting lists, and lack of clarity around entitlements.
Researchers developed an experimental drug, 32-134D, that inhibits HIF protein levels, reducing blood vessel production and leakiness in diabetic eyes. The study shows promising results in both human cell models and mice, suggesting a safer therapeutic approach for diabetic eye disease.
Researchers used AI models to predict effective peptide sequences for safe drug delivery in eye cells, promising new treatments for glaucoma and macular degeneration. The model accurately predicted a peptide sequence that bound to melanin, releasing medications over several weeks.
A patient in Cleveland was diagnosed with a corneal ulcer caused by Pseudomonas aeruginosa, a drug-resistant bacterium that's rarely found in eye infections. The contaminated eye drops were identified as the source of infection, and treatment required strong antibiotics to prevent vision loss.
Researchers at UCI have discovered new small-molecule drugs that show promise in treating age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. The treatments, called 'Stress Resilience-Enhancing Drugs,' slow or halt disease progression in animal models.
A team of researchers from UNIGE and Beihang University has identified the FOXI3 gene as responsible for one form of Goldenhar syndrome, a rare congenital disorder. Pathogenic variants in both copies of the FOXI3 gene are necessary for the disease to develop, following an autosomal recessive inheritance pattern.
The study reveals that mammals diversified before the K-Pg extinction, driven by continental drifting and stability following the mass extinction. This led to the rich diversity of mammal lineages, including carnivores, primates, and hoofed animals.
Cedars-Sinai investigators have discovered a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using human induced pluripotent stem cells. The new approach uses cells derived from iPSCs that are renewable, scalable, and can delay disease progression in rodents.
Researchers genetically engineered neural progenitor cells to release a neuroprotective protein, preventing neuron death in animal models of ALS and retinal disease. Engineered NPCs successfully preserved vision in rats with retinal disease.
Researchers have found a new target and drug combination that appears to stop the destruction of vision in premature newborns. By blocking ACAT1, an enzyme that converts cholesterol into smaller pieces, scientists can prevent the formation of leaky blood vessels and inflammation in the retina.
A novel gene therapy approach decreases intraocular pressure in pre-clinical models of glaucoma. The treatment uses a viral vector to deliver instructions to cells, producing an enzyme that helps reduce fluid accumulation and pressure. This breakthrough holds promise for patients with glaucoma.
Researchers have built a new model to examine Usher Syndrome, a leading cause of combined deafness and blindness. The model replicates the visual problems not addressed by previous models, offering insight into strategies for designing therapeutic interventions.
A research team from Université Laval has identified a method to save corneal cells from death using healthy mitochondria, reducing mortality rates from 60% to 10%. This approach demonstrates high therapeutic potential for mitochondrial injection, which could maintain vision without transplantation if diagnosed at an early stage.
Researchers at Duke-NUS Medical School have achieved significant vision recovery in experimental models of damaged retinas using stem cells. The study marks a promising step towards potentially restoring vision in eye diseases characterized by photoreceptor loss.
A team of scientists led by Dr Gerrit Hilgen have won funding to research age-related macular degeneration, a common disease affecting over 190 million people worldwide. The £100,000 award will support the study of human induced pluripotent stem cell models and help develop new treatments for the condition.
A recent study revealed the key to a protein that commonly causes blindness, including its role in transporting toxic compounds out of the eye. Mutations in this protein can cause vision loss in diseases like Stargardt disease, which affects approximately 30,000 people nationwide.
A team from the National Eye Institute identified Reserpine as a compound that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10, an inherited retinal ciliopathy disease. The study suggests a potential treatment strategy for addressing retinal ciliopathies caused by multiple genes.
Researchers have developed a non-invasive method to track human aging using retinal scans, which are less expensive and more accurate than other aging clocks. The study found that changes in the eye can provide an actionable evaluation of gero-protective therapeutics, offering a new tool for tracking aging.
Researchers developed a new form of omega-3 fatty acid DHA that can cross into the retina, increasing retinal DHA content and preserving function. This approach overcomes previous barriers and shows promise for preventing Alzheimer's-related declines in visual function.
A new study suggests that age, not weight, should be used to screen for diabetes, capturing the greatest number of people in all racial and ethnic groups. The approach identifies the greatest proportion of adults with prediabetes and diabetes and maximizes equity across racial and ethnic groups.
Corneal graft rejection can be as high as 10% due to poor patient compliance with medications, which require frequent eyedrop administrations. Researchers at Virginia Commonwealth University developed nanoparticles to encapsulate eye medication, decreasing graft rejection while requiring fewer and smaller doses. The approach reversed s...
Young children with autism spectrum disorder are less likely to undergo vision screening than their peers, despite a high risk of developing serious eye disorders. A recent study found that only 36.5% of children with ASD had completed vision screenings at well visits, compared to 59.5% for children without ASD.
Researchers have successfully restored vision in mice with retinitis pigmentosa using a new CRISPR-based genome editing technique. The PE SpRY system corrected genetic mutations and restored normal electrical responses to light, preserving vision into old age. This breakthrough offers potential for treating inherited blindness.
A meta-analysis of 34 studies found a significant association between autism spectrum disorder (ASD) and increased risks of developing diabetes, dyslipidemia, and heart disease. Children with ASD were more likely to develop these metabolic complications, prompting clinicians to monitor them closely.
Researchers used UK Biobank image and genomic data to uncover insights into rare retinal dystrophies, a leading cause of blindness in working-age adults. The study identified new genetic associations with the thickness of photoreceptor cell layers, offering new avenues for research and diagnosis.
Researchers have mapped changes to the retina that correspond to brain changes in Alzheimer's disease patients, opening a path to earlier diagnosis and more effective treatments. The study found accumulation of toxic proteins in retinas of patients with Alzheimer's disease and mild cognitive impairment, causing severe cell degeneration.
UVA scientists have discovered a new contributor to abnormal blood vessel growth in the eye, which could lead to new treatments for macular degeneration and other vision loss conditions. The discovery identifies a key protein that determines VEGF levels, blocking it has reduced VEGF levels significantly without unwanted side effects.
Researchers from Tokyo Medical and Dental University investigated the safety of anti-VEGF drug Aflibercept in a cell culture model exposed to HTLV-1. The study found that treatment did not increase pro-viral load or proliferation of RPE cells, suggesting potential for intraocular use.
A new nonhuman primate model of Usher syndrome has been confirmed, providing hope for the development of a treatment for this leading cause of blindness-deafness. The model, created using CRISPR/Cas9 technology, exhibits symptoms similar to those experienced by humans with the condition.